A resolution expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.

This Senate resolution expresses the non-binding opinion that federal laws regarding medication abortion should rely on scientific evidence rather than political influence. It specifically calls for the FDA to maintain its approval of mifepristone, a drug proven safe and effective over 25 years, and to allow patients to access it through telemedicine or mail-order pharmacies. The measure highlights that current restrictions disproportionately harm marginalized communities, including people of color, low-income individuals, and those in rural areas. By stating these points, the resolution aims to encourage policymakers to ensure equitable and transparent access to abortion care based on medical consensus.